Clinical trial Recruiting at 1 site Observational Ages 25 to 85

Using Chinese herbal medicine for recovery after heart surgery

Official title: Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

Run by Peking University Third Hospital · NCT06961136 · Data updated 2026-11-12

This study is testing whether a traditional Chinese herbal medicine can help people recover faster after heart surgery compared to a placebo.

Quick facts

Study typeObservational
Ages25 Years to 85 Years
SexAll
Enrollment300 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 10, 2025
Main results expectedJune 1, 2026
Study endsJune 30, 2026
Registry record updatedMay 8, 2026
Trial IDNCT06961136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have undergone CABG and exhibit symptoms of Qi-Yin deficiency.

Probably not a fit

Patients with severe postoperative complications or those allergic to the herbal treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of the Fuzheng Yangxin prescription on the rapid rehabilitation of patients who have undergone coronary artery bypass grafting (CABG) and are diagnosed with Qi-Yin deficiency syndrome. The study aims to assess the efficacy of this traditional Chinese herbal treatment compared to a placebo in improving recovery outcomes post-surgery. Participants will be monitored for their recovery progress and overall health status following the intervention. The study is particularly relevant given the rising prevalence of coronary heart disease and the increasing number of CABG procedures performed annually.

Why it matters

Potential benefit: If successful, this study could provide a novel herbal treatment option to enhance recovery for patients after heart surgery.

How similar studies have gone: While the use of traditional Chinese medicine in post-operative care is gaining interest, this specific approach has not been widely tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who received coronary artery bypass surgery with syndrome differentiation of Qi-Yin deficiency after operation

Exclusion Criteria:

* ① Patients allergic to Fuzheng Yangxin Fang granules

  * Patients with postoperative cold and fever ③ Patients with severe postoperative hepatic and renal insufficiency ④ Other circumstances: Concurrent valvular surgery or other cardiac surgery, end-stage malignant tumor, uncontrolled infection, bleeding, progressive degenerative systemic disease, severe brain injury, multiple organ failure, other vital organ dysfunction such as severe liver impairment, severe heart failure or cardiogenic shock, inability to tolerate surgery, etc.

Where it's running

  • Peking university third hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.